SCHEMBL525965

SCHEMBL525965

[CH2]CC=CCCC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1541653 1.00
SCHEMBL1541523 0.90
SCHEMBL1541525 0.90
SCHEMBL5857075 0.89
SCHEMBL5985965 0.89
SCHEMBL3221401 0.88 FAAH (0.33)
SCHEMBL5987306 0.88 FAAH (0.33)
SCHEMBL5986195 0.88 FAAH (0.33)
SCHEMBL5984500 0.88 FAAH (0.33)
SCHEMBL5984220 0.88 FAAH (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0303282-A2 Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers ATOCHEM NORTH AMERICA, INC. (US) 1989-02-15 EP claimed
US-20240197724-A1 THERAPEUTIC AGENT FOR GAIT DISTURBANCE NIPPON SHINYAKU CO., LTD. (JP) 2024-06-20 US disclosed
EP-4316489-A1 THERAPEUTIC AGENT FOR GAIT DISTURBANCE Nippon Shinyaku Co., Ltd. (JP) 2024-02-07 EP disclosed
CN-117157075-A Remedies for gait disorder 日本新药株式会社 2023-12-01 CN disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
WO-2022211052-A1 THERAPEUTIC AGENT FOR GAIT DISTURBANCE 日本新薬株式会社 2022-10-06 WO disclosed
EP-3386473-B1 OLIGOESTER AMMONIUM SALTS AND THEIR USE IN COSMETIC COMPOSITIONS CLARIANT INT LTD (CH) 2022-04-20 EP disclosed
EP-2246336-B1 FIBROSIS INHIBITOR NIPPON SHINYAKU CO LTD (JP) 2020-07-01 EP disclosed
WO-2019185409-A1 PVC COMPOSITION CONTAINING AT LEAST ONE PLASTICIZER HAVING AT LEAST ONE CARBOXYLIC ACID ESTER GROUP, AND CONTAINING AT LEAST ONE CARBODIIMIDE COMPOUND BASF SE (DE) 2019-10-03 WO disclosed
US-20190055376-A1 PLASTICIZER COMPOSITION CONTAINING POLYMERIC DICARBOXYLIC ACID ESTERS AND PHTHALIC ACID DIALKYL ESTERS BASF SE (DE) 2019-02-21 US disclosed
US-4346709-A Drug delivery devices comprising erodible polymer and erosion rate modifier ALZA CORPORATION (US) 1982-08-31 US disclosed
EP-0052916-A2 Erodible polymer containing erosion rate modifier ALZA CORPORATION (US) 1982-06-02 EP disclosed
US-4322323-A Erodible device comprising surfactant for modifying the rate of erosion of the device ALZA CORPORATION (US) 1982-03-30 US disclosed
US-4282201-A Pharmaceutical comprising drug and polymer ALZA CORPORATION (US) 1981-08-04 US disclosed
US-4259102-A Composition comprising useful agent such as fertilizers, housed in heterocyclic polymer ALZA CORPORATION (US) 1981-03-31 US disclosed
US-4246397-A Polymers comprising heterocyclic system ALZA CORPORATION (US) 1981-01-20 US disclosed
US-4180646-A BIOERODABLE SUSTAINED RELEASE COTAINGS ALZA CORPORATION (US) 1979-12-25 US disclosed
US-4138344-A Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) ALZA CORPORATION (US) 1979-02-06 US disclosed
US-4131648-A POLYMERIC MATERIALS ALZA CORPORATION (US) 1978-12-26 US disclosed
US-4093709-A Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) ALZA CORPORATION (US) 1978-06-06 US disclosed